White label – Pompe disease - ClinicalTrials.eu

Study of Pembrolizumab with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated Drugs:
Study on the Safety and Effectiveness of THE-630 for Patients with Advanced Gastrointestinal Stromal Tumors (GIST)

Not recruiting

2 1 1
Investigated Drugs:
- The-630
Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette’s Disorder

Not recruiting

3 1
Investigated Diseases:
- Tourette’s disorder
Investigated Drugs:
- Ecopipam Hydrochloride
+3
Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Kidney transplant rejection
Investigated Drugs:
- Imlifidase
+2
Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

3 1 1
Investigated Drugs:
+5
Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn’s Disease After Anti-TNF Therapy Failure

Not recruiting

3 1 1 1
Investigated Drugs:
- Risankizumab
- Ustekinumab
+8
Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

Not recruiting

3 1
Investigated Diseases:
- Neurotrophic keratopathy
Investigated Drugs:
- Timbetasin Acetate
Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Not recruiting

3 1
Investigated Diseases:
- Schizophrenia
Investigated Drugs:
- Valbenazine Ditosylate
Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

Not recruiting

4 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- 3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid
+1
Study on Reversing Muscle Relaxation in Elderly Patients (75+) Using Sugammadex or Neostigmine/Glycopyrrolate During Laparoscopic Surgery

Not recruiting

3 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies